Lilly Shares Jump On 7.9% Weight Loss Pill Eli Lilly said on Thursday its experimental pill, orforglipron, led to weight loss of nearly 8% at the highest dose and lowered blood sugar in patients with type 2 diabetes in a late-stage trial. By ryounglao|2025-04-17T10:33:19-04:00April 17, 2025|International News|0 Comments Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: ryounglao Related Posts Hermes To Pass On Tariff Costs To U.S. Clients Hermes To Pass On Tariff Costs To U.S. Clients UnitedHealth Shares Tank On Steep Forecast Cut UnitedHealth Shares Tank On Steep Forecast Cut TSMC Q1 Profit Surges 60%, Beats Forecasts TSMC Q1 Profit Surges 60%, Beats Forecasts Stocks Eke Out A Gain As Traders Scour Earnings Stocks Eke Out A Gain As Traders Scour Earnings Leave A Comment Cancel replyComment Save my name, email, and website in this browser for the next time I comment. Δ
Leave A Comment